Cargando…
Emerging and Novel Treatments for Pituitary Tumors
A subset of pituitary neuroendocrine tumors (PitNETs) have an aggressive behavior, showing resistance to treatment and/or multiple recurrences in spite of the optimal use of standard therapies (surgery, conventional medical treatments, and radiotherapy). To date, for aggressive PitNETs, temozolomide...
Autores principales: | Ilie, Mirela Diana, Lasolle, Hélène, Raverot, Gérald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723109/ https://www.ncbi.nlm.nih.gov/pubmed/31349718 http://dx.doi.org/10.3390/jcm8081107 |
Ejemplares similares
-
Aggressive corticotroph tumors and carcinomas
por: Lasolle, Hélène, et al.
Publicado: (2022) -
The Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications
por: Ilie, Mirela Diana, et al.
Publicado: (2019) -
SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors
por: Castellnou, Solène, et al.
Publicado: (2020) -
OR23-04 SST5 Expression and USP8 Mutation in Functioning and Silent Corticotroph Pituitary Tumors
por: castellnou, Solene, et al.
Publicado: (2020) -
Gonadotroph Tumors Show Subtype Differences that Might Have Implications for Therapy
por: Ilie, Mirela Diana, et al.
Publicado: (2020)